Molecular Imaging Technologies, LLC (“MIT”) is an outsourced provider of positron emission tomography-computed tomography (“PET/CT”) equipment and services to healthcare facilities throughout the U.S. The Company’s value proposition is to assuage the lofty capital investment that healthcare providers face while also providing turn-key operational and marketing program that integrates into a provider’s workflow. On September 15, 2020, MIT was sold to Alliance Healthcare Services.

Investment Profile:

Status: Realized

Investment Date: September 15, 2011

Transaction Type: Recapitalization (Chapter 11 Plan Purchase)

Strategy: Transformation

Station Lead(s): Rooke

Investment Highlights:

Successful Acquisitions: Metro Region PET Center (Chevy Chase, MD), Oncology Molecular Imaging (5 Locations), Affiliated PET Systems (Silver Spring, MD).
Sale of Core Businesses: Sold core business to strategic buyer in September 2020.
Conversion & Sale of Gadsden PET: Sold last remaining location to a physician group.